Page last updated: 2024-12-07

3,4-dimethoxybenzylamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3,4-dimethoxybenzylamine: RN given for parent cpd; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID79832
SCHEMBL ID44393
MeSH IDM0190825

Synonyms (54)

Synonym
HMS1749O10
4-13-00-02582 (beilstein handbook reference)
3,4-dimethoxybenzylamine
benzenemethanamine,4-(dimethoxy)-
veratrylamine
nsc271740
benzenemethanamine,4-dimethoxy-
5763-61-1
benzylamine,4-(dimethoxy)-
nsc-271740
wln: z1r co1 do1
3,4-(dimethoxy)benzylamine
inchi=1/c9h13no2/c1-11-8-4-3-7(6-10)5-9(8)12-2/h3-5h,6,10h2,1-2h
3,4-dimethoxybenzylamine, 97%
benzylamine, 3,4-dimethoxy-
nsc 271740
benzenemethanamine, 3,4-dimethoxy-
einecs 227-287-7
brn 0511575
STK397311
1-(3,4-dimethoxyphenyl)methanamine
(3,4-dimethoxyphenyl)methanamine
AKOS000120468
D4024
FT-0635841
BBL027681
SCHEMBL44393
veratrylamin
3,4-dimethoxyphenylmethyl amine
3,4-dimethoxy -benzylamine
3,4-dimethoxybenzenemethanamine
3,4-dimethoxy benzyl amine
1-(3,4-dimethoxyphenyl)methaneamine
1-(aminomethyl)-3,4-dimethoxybenzene
3,4-dimethoxybenzyl-amine
3,4-dimethoxy-benzylamine
3,4-dimethoxybenzyl amine
3,4-dimethoxy benzylamine
3,4-di-methoxybenzylamine
benzylamine, 3,4-(dimethoxy)-
(3,4-dimethoxyphenyl)methanamine #
W-105453
TS-01461
F0001-1502
DTXSID50206292
mfcd00008116
(3,4-dimethoxybenzyl)amine
BCP18641
KQA442BL6W
[(3,4-dimethoxyphenyl)methyl]amine
EN300-17919
JHD ,
CK2400
CS-W017837
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (16.67)18.7374
1990's3 (50.00)18.2507
2000's0 (0.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.06

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.06 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.71 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.06)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]